![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Lymphoma, Large-cell - 75 Studies Found
Active, not recruiting |
: Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders :
|
Active, not recruiting |
: Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant :
: |
Active, not recruiting |
: Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas :
|
Completed |
: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies :
: |
Completed |
: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies :
: |
Completed |
: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant :
: |
Terminated |
: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma :
|
Terminated |
: Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer :
|
Completed |
: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery :
|
Completed |
: RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors :
|